KING'S COLLEGE LONDON
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Colleges, Universities, and Professional Schools, Commercial Economic, Sociological, and Educational Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about KING'S COLLEGE LONDON
Live alerts from global media, monitored by Business Radar
2024-06-22 (cnbcindonesia.com)
King's College London invests US$ 2 million in KEK Singhasari
King's College London will open a campus in the Singhasari Special Economic Zone (KEK).
Read more
2024-06-21 (asiatoday.id)
Investing US$ 2 Million, King’s College London Opens Campus in SEZ Singhasari
ASIATODAY.ID, JAKARTA - King's College London (KCL) has officially received permission to develop education in the Singhasari Special Economic Zone
Read more
2024-01-05 (fenews.co.uk)
Netcom Training Secures Contract worth £2.4 Million from Department for Education to Deliver Digital Skills Bootcamps Across England | FE News
| Netcom Training Secures Contract worth £2.4 Million from Department for Education to Deliver Digital Skills Bootcamps Across England
Read more
2023-08-23 (indiaeducationdiary.in)
King’s College London receives NIHR investment
For medical trainees, the NIHR Integrated Academic Training (IAT) programme enables individuals to undertake academic and clinical training concurrently at partners Guy’s and St Thomas’, King’s College Hospital and South London and Maudsley NHS Found
Read more
2023-07-25 (indiaeducationdiary.in)
King’s College London receives £6.8 million from NIHR
Led by Professor Richard Emsley, the Research Support Service (RSS) managed by King’s College London will form part of a national network of eight RSS hubs which will start work from 1 October 2023.The scheme replaces the NIHR Research Design Service
Read more
2021-12-02 (standard.co.uk)
Gene therapy pioneer developing cure for dementia raises $80m for clinical trials
A biotech spun out of King’s College London has raised $80 million (£56 million) to fund clinical trials of its “revolutionary” gene therapies with the potential to cure dementia.
Read more